This article explores the development and validation of a new enzyme-linked immunosorbent assay (ELISA) with high sensitivity and selectivity for bioanalysis of bevacizumab (BEV), a monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results